Nasdaq agrx.
Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...
PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the ...See the latest Agile Therapeutics Inc stock price (AGRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.PRINCETON, N.J., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended September 30 ...Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.The principal risks of investing in the Fund are: Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole.
Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.
As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.
AGRX Agile Therapeutics Inc Agile Therapeutics Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ('Agile' or the 'Company'), a women's healthcare company, today announced that it has received written noti...PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Agile Therapeutics, Inc. (NASDAQ: AGRX) (after the close) Tuesday . Boston Scientific Corporation (NYSE: BSX) (before the market open) Masimo Corporation (NASDAQ: MASI) (after the close)PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Dennis P. Reilly as Chief Financial ...
Sep 27, 2023 · Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its ...
Shares of NASDAQ AGRX opened at $2.16 on Friday. Agile Therapeutics has a one year low of $1.65 and a one year high of $16.00. The firm has a market capitalization of $5.43 million, a PE ratio of -0.16 and a beta of 1.85. The business has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $2.54.
Agile Therapeutics Inc (NASDAQ:AGRX) is the most popular stock in this table. On the other hand FedNat Holding Co (NASDAQ:FNHC) is the least popular one with only 7 bullish hedge fund positions.Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Penny Stocks With Room to Run: Agile Therapeutics (AGRX) Agile Therapeutics is a women’s healthcare company that makes and commercializes women’s prescription contraceptive products. It was ...Stock Symbol NASDAQ:AGRX. Total Funding Amount $240.8M. Total Funding Amount . Unlock for free . Contacts 32. Employee Profiles 7. Investors 12. Similar Companies 25. Recent News & Activity. News • Oct 4, 2023. GlobeNewswire News Room — Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under …Agile Therapeutics Inc (NASDAQ: AGRX) expects Q2 FY22 Twirla demand to be at the mid-point of the earlier provided outlook of 20,000 - 22,000 cycles (new range 21,000 - 21,500 cycles). It ...
The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...PRINCETON, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has ...Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued ...PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...
Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.
Nov 29, 2023 · Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient ... PRINCETON, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three and nine months ended ...PRINCETON, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced a positive outcome from today’s meeting of the Bone ...PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...The latest price target for . Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on September 22, 2023.The analyst firm set a price target for $5.00 expecting AGRX to rise to within 12 ... PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after ...Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. AGRX has an Altman Z-Score of -49.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Agile Therapeutics, Inc. (AGRX) stock, including valuation metrics, financial numbers, share information and more.
The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”
EQS-News: Agile Therapeutics, Inc. NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 21.10.2022 / 17:00 CET/CEST The issuer is solely responsible for the...
Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript. Mar 30, 2022.PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript 5 Cheap Pharmaceutical Stocks For 2022 5 Best Penny Stocks to Buy and Hold According to Reddit Agile Therapeutics, Inc ... PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...PRINCETON, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of ...AGRX U.S.: Nasdaq Agile Therapeutics Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 15, 2023 10:21 a.m. EST Real time quote $ 2.2182 0.3182 16.75% Previous Close $1.9000... Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. Mangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill Formula. Dallas, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men's …AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ...Shares of NASDAQ AGRX opened at $2.16 on Friday. The firm has a market capitalization of $5.42 million, a PE ratio of -0.16 and a beta of 1.81. The firm’s 50-day moving average is $1.99 and its ...PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …
PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ...PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Instagram:https://instagram. earthquake insurance farmerslargest data center reitsnly tickeripo calender PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... nvidia predictionsfidelity capital appreciation The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.” amazon stock spliy AGRX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / PRINCETON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced that it has ...Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.